Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
3-bromo-N'-[(1E)-(3,5-dibromo-2,4-dihydroxyphenyl)methylidene]benzohydrazide
- Development stage
- Unknown
- Modality
- Small Molecules
01
Overview
3-bromo-N'-[(1E)-(3,5-dibromo-2,4-dihydroxyphenyl)methylidene]benzohydrazide is a synthetic small molecule belonging to the class of organic compounds known as 3-halobenzoic acids and derivatives. It features a dibrominated dihydroxyphenyl group linked via a hydrazone bond to a bromobenzoyl moiety. The compound has been cataloged in DrugBank (DB07044) as an experimental agent with no current approved indications or clinical trial activity. Its precise mechanism of action and biological targets are not well characterized in public databases. However, related hydrazone derivatives have been investigated for potential antioxidant, antimicrobial, anticancer, and anti-inflammatory properties due to their ability to interact with various biological targets through their halogenated aromatic rings and hydrazone linkages[1][5].
- Other names
- 3-bromo-N'-[(1E)-(3,5-dibromo-2,4-dihydroxyphenyl)methylidene]benzohydrazide
Beyond the preview
Go deeper on 3-bromo-N'-[(1E)-(3,5-dibromo-2,4-dihydroxyphenyl)methylidene]benzohydrazide.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on 3-bromo-N'-[(1E)-(3,5-dibromo-2,4-dihydroxyphenyl)methylidene]benzohydrazide.